Navigation Links
Glivec the hot cancer drug from Novartis

Novartis is the world's sixth-largest drugmaker (by sales).
Novartis was formed after merger of two Swiss companies, Sandoz Ltd. and Ciba-Geigy."Novartis is emerging as one of the premier powerhouses in the global pharmaceuticals industry," says Richard R. Stover, senior analyst with brokerage Natexis Bleichroeder Inc. in New York. The new cancer drug, Glivec's success led to Novartis reported a 24% jump in first-quarter operating earnings, to $1.4 billion, on sales of $5.7 billion. The stock has climbed 15% since mid-March and continues to outperform the industry.

Glivec was first approved for treatment of chronic myeloid leukemia. It is the first treatment ever proven drug to cause certain types of tumors to disappear. While other cancer drugs killsoff healthy cells along with sick ones, Glivec interfere with the proteins that cause tumors to grow. Glivec also is used to treat other rare types of cancer such as gastrointestinal stromal tumors (GIST) and is now being tested in combination with other drugs in fighting prostate cancer.

Glivec was introduced in the U.S. in 2001 under the brand name Gleevec. Sales rose more than 300% in 2002, and could hit the $1 billion mark by the end of this year. Although an annual course of Glivec can cost as much as $25,000, demand for the drug took off so quickly that Novartis was forced to run its production line around the clock.

Since the year 2000 Novartis has launched 10 drugs and this is three times more than its nearest rival. Another 15 are expected to debut by 2006. Among the current crop are Zelmac, a drug for irritable-bowel syndrome;eczema treatment Elidel; and Zometa, a treatment for bone metastases.
'"/>




Page: 1

Related medicine news :

1. Glivec - New Hope For CMC Patients
2. Glivec Enhances Survival Rates In Leukemia
3. Vitamin B12 can help in detecting cancers
4. Want skin cancer? Please have a cigarette
5. New hope for cancer victims – will vaccine cure the deadly bug
6. Clintons new problem - Is the outgoing American president suffering from skin cancer?
7. Are cancer patients being taken for a ride?
8. Breast cancer treatment to be determined by gene test
9. Ductal lavage may detect early breast cancer
10. Beware of the oral patch! It could be cancer!!!
11. New drug helps boost cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... LONDON , June 23, 2016 ... environments  Oticon , industry leaders in ... the launch of Oticon Opn ™, the world,s ... world of possibilities for IoT devices.      ... Opn, Oticon introduces a number of ,world firsts,: ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Surgical Procedure Volumes: Global Analysis (United States, China, Japan, ... report to their offering. ... tool for healthcare business planners, provides surgical procedure volume ... surgery trends with an in-depth analysis of growth drivers ...
(Date:6/23/2016)...  The National Pharmaceutical Council (NPC) today announced ... research organization as its newest member.  ... president and chief scientific officer, Mallinckrodt Pharmaceuticals, will ... Board of Directors. ... us in support of our efforts to conduct ...
Breaking Medicine Technology: